Filters
Study Phase
Recruitment Status
Study Type
Eligibility Sex
Healthy Volunteers
Sort by:
Need a comprehensive medical report on "RNA"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Phase 2
- Conditions
- Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin LymphomaAdult Nodular Sclerosis Hodgkin LymphomaStage II Adult Hodgkin LymphomaStage III Adult Hodgkin LymphomaStage IV Adult Hodgkin Lymphoma
- Interventions
- Procedure: quality-of-life assessmentGenetic: DNA analysisGenetic: RNA analysisRadiation: fludeoxyglucose F 18Procedure: positron emission tomographyOther: laboratory biomarker analysisOther: immunohistochemistry staining methodGenetic: polymorphism analysis
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 48
- Registration Number
- NCT01476410
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Stanford University Medical Center, Stanford, California, United States
🇺🇸Memorial Sloan- Kettering Cancer Center, New York, New York, United States
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
Phase 3
Completed
- Conditions
- Acquired Immunodeficiency Syndrome (AIDS) VirusHuman Immunodeficiency Virus (HIV) Infections
- Interventions
- First Posted Date
- 2011-10-07
- Last Posted Date
- 2017-11-27
- Lead Sponsor
- Janssen-Cilag International NV
- Target Recruit Count
- 274
- Registration Number
- NCT01448707
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Completed
- Conditions
- Lung Cancer
- Interventions
- Genetic: DNA analysisGenetic: DNA methylation analysisGenetic: RNA analysisGenetic: gene expression analysisGenetic: polymorphism analysisOther: laboratory biomarker analysisOther: medical chart review
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2017-06-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 248
- Registration Number
- NCT01414595
- Locations
- 🇺🇸
Union Hospital of Cecil County, Elkton, Maryland, United States
🇺🇸Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
HIV Diagnosis in Hospitalized Malawian Infants
Not Applicable
Completed
- Conditions
- HIV Infections
- Interventions
- Device: Point of care HIV RNA PCR
- First Posted Date
- 2011-07-06
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 300
- Registration Number
- NCT01388452
- Locations
- 🇲🇼
Kamuzu Central Hospital, Lilongwe, Malawi
Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer
Phase 1
Withdrawn
- Conditions
- Recurrent Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Other: pharmacological studyGenetic: RNA analysisGenetic: polymerase chain reaction
- First Posted Date
- 2011-06-28
- Last Posted Date
- 2020-04-01
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT01383668
Autologous Redirected RNA Meso-CIR T Cells
Phase 1
Completed
- Conditions
- Malignant Pleural Mesothelioma
- Interventions
- Biological: Autologous T cells
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2017-09-19
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 18
- Registration Number
- NCT01355965
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT01344642
- Locations
- 🇨🇦
The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada
Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
Phase 2
Completed
- Conditions
- Anaplastic Large Cell LymphomaHepatosplenic T-cell LymphomaAngioimmunoblastic T-cell LymphomaPeripheral T-cell Lymphoma
- Interventions
- Other: laboratory biomarker analysisGenetic: comparative genomic hybridizationGenetic: gene expression analysisGenetic: nucleic acid sequencingGenetic: mutation analysisOther: immunohistochemistry staining methodGenetic: microarray analysisGenetic: RNA analysis
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 34
- Registration Number
- NCT01336933
- Locations
- 🇺🇸
University of Massachusetts Medical School, Worcester, Massachusetts, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Biomarkers in Tissue Samples From Young Patients With Liver Cancer
Completed
- Conditions
- Childhood HepatoblastomaStage I Childhood Liver CancerStage III Childhood Liver CancerStage IV Childhood Liver CancerStage II Childhood Liver Cancer
- Interventions
- Genetic: RNA analysisGenetic: gene expression analysisGenetic: microarray analysisGenetic: nucleic acid sequencingOther: diagnostic laboratory biomarker analysis
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 99
- Registration Number
- NCT01336881
- Locations
- 🇺🇸
Children's Oncology Group, Monrovia, California, United States
The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART
- First Posted Date
- 2011-03-21
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 25
- Registration Number
- NCT01319383
- Locations
- 🇺🇸
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath